MCA 35

INNOAESTHETICS

Aesthetic / Dermatology Product

Professional chemical peel (biorevitalizing chloroacetic acid peel)

INNO EXFO professional chemical peels are described by distributors as class III medical devices in the EU/EEA market, requiring CE marking and conformity with applicable medical device regulations.
Laboratorio Innoaesthetics, S.L.U. manufactures chemical peels and other aesthetic products in facilities that operate under ISO 13485 (medical devices quality management) and ISO 22716 (cosmetic GMP) for relevant product categories.
Products are intended exclusively for professional use, and some distributors may require proof of medical or aesthetic professional qualification before supply.

INNO EXFO professional chemical peels are described by distributors as class III medical devices in the EU/EEA market, requiring CE marking and conformity with applicable medical device regulations.
Laboratorio Innoaesthetics, S.L.U. manufactures chemical peels and other aesthetic products in facilities that operate under ISO 13485 (medical devices quality management) and ISO 22716 (cosmetic GMP) for relevant product categories.
Products are intended exclusively for professional use, and some distributors may require proof of medical or aesthetic professional qualification before supply.

Professional chemical peel (biorevitalizing chloroacetic acid peel)

Description

INNO-EXFO MCA 35 by INNOAESTHETICS is a professional, biorevitalizing chemical peel based on chloroacetic acid (CA) combined with salicylic acid and arbutin, delivered with Smart GPS® technology. It is indicated for general cutaneous biorevitalization and the treatment of hypotonic and atrophic skin, elastosis of the face, neck and neckline, fine lines and wrinkles, and as an adjuvant in hyperpigmentation protocols. MCA 35 provides controlled micro-exfoliation and dermal redensification without frosting (NO FROST), restoring skin energy, elasticity and radiance. The product is supplied for professional use only in a pack of 5 vials of 5 ml each.

Bnefits

Powerful skin biorevitalizer with intense activity against signs of aging and fine lines.
Resurfacing peel that promotes dermal regeneration and revitalization, helping the skin regain energy, elasticity and radiance.
Anti-ageing, firming, restructuring and toning effects on photo-aged, hypotonic or atrophic skin.
Improves elastosis on the face, neck and neckline by redensifying dermal and epidermal layers.
Adjuvant in hyperpigmentation treatments due to the depigmenting, skin-brightening action of arbutin.
Controlled microexfoliation (NO FROST) with mild peeling and short downtime (typically 1–2 days).
Uses Smart GPS® (Guidance Performance System) to optimize delivery of active ingredients into target skin layers.
Suitable as part of professional anti-ageing and biorevitalization treatment protocols for younger and mature skin.

Indications

General cutaneous biorevitalization.
Hypotonic and atrophic skin.
Elastosis of the face, neck and neckline.
Fine lines and superficial wrinkles associated with photoaging.
Adjuvant (coadjuvant) treatment in protocols for hyperpigmentation and dyschromia.
Patients seeking non-injectable biorevitalization and global skin quality improvement under professional supervision.

Composition

Chloroacetic Acid (CA) 35% (monochloroacetic acid, a modified trichloroacetic acid).
Arbutin 10% (depigmenting and brightening glycoside of natural origin).
Salicylic Acid 2% (keratolytic and antibacterial beta-hydroxy acid).
Smart GPS® (Guidance Performance System) transdermal delivery technology.
Excipients and vehicle components suitable for professional chemical peel formulations.
Final product pH: < 1.
Presentation: 5 ml per vial, 5 vials per pack.

Formulation

Professional-use, liquid chemical peel solution.
Active acid system based on chloroacetic acid (35%), salicylic acid and arbutin.
No-frost formulation (NO FROST) providing controlled coagulation and microexfoliation without classic white frosting.
Biorevitalizing and dermal densifying action via stimulation of dermal and epidermal remodeling.
Pack format: 5 x 5 ml glass vials (single-use per treatment area/session according to protocol).
Part of INNO-EXFO professional peel line from INNOAESTHETICS.

Packaging

Box containing 5 sterile vials of 5 ml each (total 25 ml).
Each vial labelled with product name (MCA 35), batch number, expiry date and manufacturer details.
Outer carton printed with INNOAESTHETICS / INNO-EXFO branding, indications and professional-use only statement.
Intended exclusively for medical / aesthetic professionals as a class of medical chemical peel.

Usage

Professional use only: application must be performed by trained medical or aesthetic professionals familiar with medium-depth chemical peels.
Pre-treatment: cleanse the skin thoroughly (e.g., with INNO-DERMA Soft Cleanser or Deep Cleanser) and degrease using a dedicated degreasing solution from the INNO-EXFO range.
Protect sensitive areas (eye contour, nasal folds, commissures) with petroleum jelly or an appropriate barrier cream.
Draw the required volume of MCA 35 (typically around 2 ml, depending on treatment area) from the vial.
Apply 1–3 uniform layers with a brush or gauze over the treatment area (face, neck, neckline), massaging gently if specified by protocol, and observing patient tolerance and skin response.
Monitor for mild to moderate burning sensation; degree of peel is designed to be soft to mild without visible frosting.
Leave on for the time recommended in the manufacturer’s protocol, then neutralize or remove according to the official instructions (often by rinsing with water and/or applying post-peel neutralizing product).
Apply post-peel repair cream (e.g., INNO-DERMA Skin Repair) and broad-spectrum SPF 50+ sunscreen after treatment.
Recommended course: usually a minimum of 3–4 sessions spaced about 2–3 weeks apart, adjusted to the individual’s skin condition and professional judgement.
Instruct patients on post-treatment care: avoid sun exposure and heat sources, apply repair and sun protection products as directed, do not pick or scratch flaking skin, and temporarily stop other aggressive topical treatments (e.g., retinoids, strong acids) as advised.

Contraindications

Known hypersensitivity or allergy to chloroacetic acid, salicylic acid, arbutin or any component of the formulation.
Active skin infections (bacterial, viral such as herpes simplex, or fungal) in the treatment area.
Compromised skin barrier in the treatment area (open wounds, dermatitis, eczema, severe rosacea, recent sunburn).
Recent use of oral isotretinoin (typically within the last 6–12 months, according to professional guidelines).
Pregnancy or breastfeeding, unless the treating physician decides otherwise based on risk–benefit assessment and local regulations.
History of abnormal wound healing or keloid formation in the treatment area.
Recent aggressive procedures on the same area (deep peels, ablative laser, dermabrasion) without adequate recovery time.
Patients unable or unlikely to comply with strict photoprotection and post-peel care instructions.

Adverse Effects

Expected: transient erythema, mild to moderate burning or stinging during application, and mild desquamation/peeling for a few days post-treatment.
Possible: edema, dryness, tightness, pruritus or discomfort in the treated area.
Less common but more serious: post-inflammatory hyperpigmentation or hypopigmentation (especially in darker phototypes or with inadequate sun protection), prolonged erythema, crusting or superficial erosions.
Rare: allergic or idiosyncratic reactions to one or more components, infection if post-treatment care is inadequate, or scarring in predisposed individuals.
All adverse effects and risks must be discussed with the patient before treatment and documented in informed consent according to local regulations.

Storage Conditions

Store in a cool, dry place at controlled room temperature, generally between 2 °C and 25 °C (refer to packaging for exact limits).
Keep vials in the original outer carton, protected from direct light and heat sources.
Ensure vials are tightly closed until use; once opened, follow the manufacturer’s recommendations regarding single-use and discard any remaining product from partially used vials.
Keep out of reach of children and unauthorized personnel; intended only for professional settings.

Duration

Typically performed as a course of 3\u20134 professional peel sessions, spaced approximately 2\u20133 weeks apart; exact number and interval are determined by the treating professional based on skin condition and response.

Onset

Initial improvements in skin brightness and texture may be visible within a few days after the first session (once mild desquamation resolves), with progressive biorevitalizing, firming and anti-ageing effects developing over the full course of 3\u20134 sessions.

Price	Link
EUR 102.00	https://www.france-health.com/en/dermal-filler-injection-areas/8779-mca-35-5-flacons-de-5ml-innoaesthetics.html

EUR 39.00
-1 more

$INNO-DERMA\u00ae Hair Lotion 70 ml$

France-health

INNO-DERMA® Hair Lotion 70 ml

Cosmetics

EUR 38.00
-1 more

France-health

INNO-EXFO Lightening 15g

Cosmetics

EUR 79.00
-1 more

$INNO\u2011DERMA Soft Cleanser 200\u202fml$

France-health

INNO‑DERMA Soft Cleanser 200 ml

Cosmetics

EUR 31.00
-1 more

$INNOAESTHETICS Hair Loss Control (4 \u00d7 2.5 ml)$

France-health

INNOAESTHETICS Hair Loss Control (4 × 2.5 ml)

Pharmaceuticals

EUR 55.00
-1 more

Consentz Hub

MCA 35

Description

Bnefits

Indications

Composition

Formulation

Packaging

Usage

Contraindications

Adverse Effects

Storage Conditions

Duration

Onset

Browse more Aesthetic / Dermatology Product

AGE RESCUE C 24H CREAM

AKN PURIFIER NIGHT GEL 50 g

DARK SPOT ERASER [DSE Plus+] 24H CREAM

DEEP CLEANSER 200ml

DEGREASING SOLUTION 100 ml INNOAESTHETICS

EYE REVITALIZER 15 g

GLYCO-AGE 30ml